OPC Pharmaceutical JSC (HOSE: OPC)

OPC Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	197,351	294,274	86,591	199,564	59,437	62,117
Short-Term Investments	40,352	27,018	69,345	18,516	30,335	35,000
Trading Asset Securities	68.95	68.95	159,269	68.95	68.95	68.95
Cash & Short-Term Investments	237,772	321,361	315,205	218,148	89,841	97,186
Cash Growth	5.30%	1.95%	44.49%	142.82%	-7.56%	1.68%
Accounts Receivable	200,504	219,136	162,534	126,704	138,585	141,820
Other Receivables	7,444	1,163	2,757	782.12	674.36	1,034
Receivables	207,949	220,299	165,291	127,486	139,260	164,854
Inventory	372,090	358,590	410,551	522,621	538,564	550,578
Prepaid Expenses	3,311	1,029	555.45	380.34	341.98	1,230
Other Current Assets	15,498	26,391	19,655	17,690	22,201	10,631
Total Current Assets	836,620	927,671	911,258	886,325	790,208	824,478
Property, Plant & Equipment	164,949	171,073	176,583	190,985	198,624	190,317
Long-Term Investments	24,505	24,385	24,203	23,688	25,208	23,995
Other Intangible Assets	74,259	73,928	75,031	76,131	77,231	78,331
Long-Term Deferred Tax Assets	3,121	9,523	3,155	3,305	1,770	1,606
Other Long-Term Assets	54,405	54,241	55,994	57,766	59,584	61,304
Total Assets	1,157,858	1,260,821	1,246,225	1,238,201	1,152,625	1,180,031
Accounts Payable	35,888	43,670	51,685	71,055	44,047	33,417
Accrued Expenses	45,341	82,895	92,016	93,386	86,311	103,309
Short-Term Debt	-	-	-	71,337	76,589	124,618
Current Income Taxes Payable	5,372	15,645	12,254	12,496	12,723	11,473
Current Unearned Revenue	4,498	3,262	28.45	186.75	2,364	1,073
Other Current Liabilities	214,258	226,274	212,853	241,172	215,123	212,804
Total Current Liabilities	305,357	371,747	368,836	489,633	437,157	486,696
Other Long-Term Liabilities	4,783	4,911	5,424	5,545	4,953	5,672
Total Liabilities	310,140	376,657	374,260	495,177	442,110	492,368
Common Stock	640,509	640,509	640,509	265,773	265,773	265,773
Additional Paid-In Capital	880.7	880.7	880.7	16,681	16,681	16,681
Retained Earnings	142,402	180,558	168,443	398,705	363,182	337,447
Total Common Equity	783,791	821,948	809,833	681,158	645,635	619,900
Minority Interest	63,926	62,216	62,131	61,865	64,879	67,763
Shareholders' Equity	847,718	884,164	871,964	743,023	710,515	687,663
Total Liabilities & Equity	1,157,858	1,260,821	1,246,225	1,238,201	1,152,625	1,180,031
Total Debt	-	-	-	71,337	76,589	124,618
Net Cash (Debt)	237,772	321,361	315,205	146,811	13,252	-27,433
Net Cash Growth	5.30%	1.95%	114.70%	1007.84%	-	-
Net Cash Per Share	3712.23	5017.28	4921.17	2292.11	206.90	-428.29
Filing Date Shares Outstanding	64.05	64.05	64.05	64.05	64.05	64.05
Total Common Shares Outstanding	64.05	64.05	64.05	64.05	64.05	64.05
Working Capital	531,263	555,924	542,422	396,693	353,051	337,782
Book Value Per Share	12237.01	12832.73	12643.58	10634.58	10079.98	9678.19
Tangible Book Value	709,533	748,020	734,802	605,027	568,404	541,569
Tangible Book Value Per Share	11077.64	11678.52	11472.15	9445.99	8874.21	8455.25
Buildings	-	298,115	294,247	292,887	276,647	260,404
Machinery	263,896	259,681	251,688	249,240	237,597	228,803
Construction In Progress	23,809	21,639	17,079	14,351	28,318	25,681

Source: S&P Capital IQ. Standard template. Financial Sources.